SpectrumEUTICALS - SB 500

Suppie Report

SpectrumEUTICALS

SB 500

A grade
91/100
SUPPIE SCORE
82/100
EFFICACY
High
SAFETY
98/100
CLEANLINESS

What Does SB 500 Do?

SB 500 delivers a well-researched 500 mg (10 billion CFU) dose of Saccharomyces boulardii strain DBVPG 6763, strongly supported by meta-analyses for reducing traveller's diarrhoea risk when started days before travel.
How should I dose SB 500 to help prevent traveller's diarrhoea?
Is Saccharomyces boulardii suitable to take alongside antibiotics?
What storage conditions are recommended for this probiotic?
Chat with Suppie

What Are the Benefits of SB 500?

Based on proven scientific research

Traveller's DiarrhoeaStrong
Intestinal HealthModerate
Gut Flora BalanceModerate
Gastrointestinal HealthModerate

Good For:

What Are the Side Effects of SpectrumEUTICALS SB 500?

Always consult your health practitioner if in doubt.

RiskLow Risk

Overview

Saccharomyces cerevisiae (boulardii) 500 mg (10 billion CFU) per capsule is generally well-tolerated at this dose in adults for short-term use.
Mild side effects may include flatulence, bloating or constipation, typically resolving without intervention.
Avoid in critically ill or immunocompromised individuals due to rare risk of fungemia.
No added gluten, dairy, wheat, preservatives or artificial colours/flavours; suitable for vegans.
Stable at room temperature below 25°C; follow label directions for traveller's diarrhoea dosing.

Potential Side Effects

Negative Interactions

Inactive Ingredients

Hypromellose
Low Risk

What Are the Ingredients in SpectrumEUTICALS SB 500?

Saccharomyces cerevisiae (boulardii) strain DBVPG 6763
500 mg (10 billion CFU)
hypromellose

Scan the bottle in your cupboard

Same graded report you just read — on any label, in about 10 seconds.

Download on the App Store

Dosage & Bioavailability

How the active doses and forms in SB 500 compare to the research.

Saccharomyces cerevisiae (boulardii) strain DBVPG 6763 is listed at 500 mg (10 billion CFU) per serving; without a source-specific reference range, dose adequacy cannot be graded.
Saccharomyces cerevisiae (boulardii) strain DBVPG 6763 has no distinct chemical or delivery form stated, so no product-specific absorption advantage can be established.

Frequently Asked Questions

Common questions about SpectrumEUTICALS SB 500